bPiDI is an innovative selective antagonist of alpha6beta2 nicotinic receptors, which inhibits nicotine-induced striatal dopamine (DA) release by interacting with alpha6beta2-containing nAChRs [1].
Molecular Weight:
580.33
CAS Number:
[525596-64-9]
Formula:
C22H34I2N2
Target:
AChR
T85902
* VAT and and shipping costs not included. Errors and price changes excepted